New Wave Biotech
New Wave Biotech creates bioprocess optimization software to accelerate R&D and reduce production costs of alt protein and Synbio products.
About New Wave Biotech
New Wave Biotech develops downstream process optimization software to help alternative protein and other synthetic biology products get to market quicker, cheaper, and more sustainable. Using computational modeling and AI, their software conducts virtual experiments on billions of potential processes and learns from experimental data to provide recommendations for optimization, helping biomanufacturers accelerate R&D and reduce production costs.
Company Facts
- Headquarters
- London
- Founded
- 2022
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00001_00010
- Funding Stage
- seed
- Total Funding
- $1,429,777
- Last Funding Type
- grant
- Last Funding Date
- 2025-10-07
- Website
- https://www.newwavebiotech.com/
Industries & Categories
Advanced Materials, Alternative Protein, Biotechnology, Machine Learning, SaaS, Software
Social Links
Canonical: https://fsome.com/organization/new-wave-biotech-59494 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.